ETHCET-M

60ml

ETHCET-M (2.5/4 mg) Syrup is a combination medicine that contains Levocetirizine and Montelukast. It is a very effective and potent medication used in children to treat year-round allergic symptoms like runny nose, watery eyes, sneezing, itching, hives (itchy, painful eruptions that sting), etc. This is a widely used combination medicine in providing relief from blockage of the nose.

ETHCET-M (2.5/4 mg) Syrup may cause some side effects like drowsiness, fever, rash, weakness, etc. However, these effects subside when your child adapts to this medicine. Consult your paediatrician if these symptoms persist for a long time or bother your child. Avoid giving this medicine if your child is allergic to it.

ETHCET-M (2.5/4 mg) Syrup can be taken with or without food. Finish the entire course of treatment with ETHCET-M (2.5/4 mg) Syrup, even if your child's condition gets better after giving a few doses. If your child vomits within 30 minutes after taking this medicine, give the same dose.

ETHCET-M (2.5/4 mg) Syrup should be used with caution in children with kidney or liver problems. Inform your doctor about other medicines of your child and also share the complete medical history including any problems related to heart, lung, blood disorders or birth defects as this information helps in deciding dose and planning overall treatment of your child.

Major & minor side effects for ETHCET-M (2.5/4 mg) Syrup

• Headache
• Stomach pain
• Chest tightness
• Joint pain
• Difficulty in swallowing
• Pus in urine
• Indigestion
• Skin rash
• Nausea and Vomiting
• Fever
• Cough
• Dizziness
• Diarrhoea
• Fatigue
• Blurred vision
• Dry mouth

What is it prescribed for?

• Allergic rhinitis

Allergic rhinitis is a common condition that occurs due to swelling inside the nose as a response of the immune system to external factors like allergens. It is commonly called hay fever. The usual signs and symptoms of allergic rhinitis are stuffy or runny nose, itchy and watery eyes, sneezing and sometimes swelling in the eyes. ETHCET-M (2.5/4 mg) Syrup is one of the best medicines used in treating symptoms of allergic rhinitis in children.

• Asthma

Asthma is a condition in which your child’s airways become narrow and it leads to breathing difficulty. ETHCET-M (2.5/4 mg) Syrup widen the airways and helps your child to breathe easily. It prevents the symptoms such as tightness in the chest, shortness of breath, wheezing, and coughing associated with asthma.

• Allergic skin conditions

The symptoms of allergic skin conditions are hives (itchy, painful eruptions that sting), redness, rash, swelling and itching etc. These can be seen as a response of the immune system to allergens. ETHCET-M (2.5/4 mg) Syrup is used to treat symptoms of allergic skin conditions in children.

Commonly asked questions

• How long does it take for this medicine to take effect?

The effect of ETHCET-M (2.5/4 mg) Syrup can be observed within 1 hour of taking it.

• How long do the effects of this medicine last?

The effect of ETHCET-M (2.5/4 mg) Syrup lasts for an average duration of 24 hours of taking it.

• Is it safe to consume alcohol while taking this medicine?

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is this a habit forming medicine?

No habit-forming tendencies were reported.

• Can this medicine be taken during pregnancy?

ETHCET-M (2.5/4 mg) Syrup is recommended for use in children.

• Can this medicine be taken while breast-feeding?

ETHCET-M (2.5/4 mg) Syrup is recommended for use in children.

Allergy

Avoid using ETHCET-M (2.5/4 mg) Syrup if your child is allergic to it or any other formulation containing it. Seek immediate medical attention if there are major allergic reactions such as skin rash, itching/swelling (especially of your face/tongue/throat), severe dizziness, breathing difficulties, etc.

Kidney Disease

Do not use ETHCET-M (2.5/4 mg) Syrup in children with severe kidney problems due to the increased risk of severe side effects.

Galactose intolerance

Avoid giving ETHCET-M (2.5/4 mg) Syrup, if your child has galactose intolerance (a condition where galactose, a type of sugar present in milk, cannot be converted to glucose) or glucose-galactose malabsorption.

Warnings for special population

Pregnancy

ETHCET-M (2.5/4 mg) Syrup is recommended for use in children.

Breast-feeding

ETHCET-M (2.5/4 mg) Syrup is recommended for use in children.

General warnings

Acute asthma

ETHCET-M (2.5/4 mg) Syrup can prevent asthma, but it is not effective in treating acute or severe asthmatic episodes.

Behaviour and mood changes

ETHCET-M (2.5/4 mg) Syrup may cause changes in behaviour and mood. Symptoms such as agitation, depression, irritability, anxiety, etc., should be reported to your doctor immediately.

Missed Dose

If you missed giving a dose, give it as soon as you remember. If your child vomits within 30 minutes after taking ETHCET-M (2.5/4 mg) Syrup give the same dose again. Skip the missed dose if it is time for the next dose.

Overdose

Never give more than the prescribed dose to your child. Consult your doctor if you suspect that you might have given an overdose of ETHCET-M (2.5/4 mg) Syrup.

All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Interaction with Medicine

Alprazolam

Fluconazole

Phenytoin

Codeine

Phenobarbital

Disease interactions

Kidney diseases

Children with mild to moderate kidney impairment need special consideration while using ETHCET-M (2.5/4 mg) Syrup as this medicine may cause serious undesirable effects. Dose adjustment may be needed.

Liver disease

ETHCET-M (2.5/4 mg) Syrup should be used with extreme caution in children with liver problems as this medicine may worsen the condition. It is not recommended to use in children with severe liver problems.

Food interactions

Information not available.

Lab interactions

Information not available.

This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.

ETHCET-M (2.5/4 mg) Syrup can be taken with or without food, as directed by your physician. Do not give more than the prescribed dose. Ensure that the course of treatment is completed. Do not stop the use of ETHCET-M (2.5/4 mg) Syrup without consulting your doctor.

Store ETHCET-M (2.5/4 mg) Syrup at room temperature protected away from heat. Keep out of reach of children and pets. Do not use it after the expiry date. Ensure that unused medicine is disposed of properly.

ETHCET-M (2.5/4 mg) Syrup is not to be mixed with any other cold and flu medicine. Follow the instructions given on the label.

Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works

Levocetirizine blocks the action of a chemical substance (histamine) produced by the body that is responsible for causing allergic symptoms. Montelukast reduces the response of certain specific chemicals (leukotrienes) that causes swelling in the airways and the nose. Thus, the combination is effective in treating allergic symptoms in your child.

Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Antihistamines, Leukotriene modifiers

Schedule

Schedule H

Bionova.co.in. 2021. Montelukast 4 mg-Levocetirizine HCL 2.5 mg-PRIMOCET Syrup. [online] Available at: < [Accessed 9 August 2021].

http://www.bionova.co.in/primocet-m-syrup.html>

CiplaMed. 2021. ETHCET-M & ETHCET-M KID DT / Syrup. [online] Available at: < [Accessed 9 August 2021].

https://ciplamed.com/content/montair-lc-montair-lc-kid-dt-syrup>

Pubchem.ncbi.nlm.nih.gov. 2021. Montelukast. [online] Available at: < [Accessed 9 August 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Montelukast>

Pubchem.ncbi.nlm.nih.gov. 2021. Levocetirizine. [online] Available at: < [Accessed 9 August 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Levocetirizine>